WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Brexpiprazole (Rexulti) in Massachusetts

Also known as: Rexulti

Find doctors, physicians, and healthcare providers who prescribe Brexpiprazole in Massachusetts. This page lists the top prescribers of Brexpiprazole based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Brexpiprazole?

REXULTI is indicated for: Adjunctive treatment to antidepressants for major depressive disorder (MDD) in adults Treatment of schizophrenia in adults and children ages 13 years and older Treatment of agitation associated with dementia due to Alzheimer's disease Limitations of Use: REXULTI is not indicated as an as needed ("prn") treatment for agitat It belongs to a class of drugs known as atypical antipsychotic.

Total Claims in Massachusetts
7,937
2.6% of all Brexpiprazole prescriptions nationwide
Total Beneficiaries in Massachusetts
286
Total Cost in Massachusetts
$12,631,798

Top Prescribers in MA(2+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Christopher BiernackiPittsfield, MAPhysician Assistant21127$345,887
Kimberly AbdowWorcester, MANurse Practitioner15625$300,455
Loading more data in background...

Find Brexpiprazole doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.